Dashboard
Poor long term growth as Operating profit has grown by an annual rate -24.13% of over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 905 Cr (Micro Cap)
150.00
40
1.08%
0.18
2.06%
3.08
Total Returns (Price + Dividend) 
Latest dividend: 7.5 per share ex-dividend date: Aug-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Fairchem Organic Sees Revision in Market Assessment Amidst Challenging Financial Trends
Fairchem Organic, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights concerns across multiple performance parameters, signalling a cautious stance among investors.
Read More
Fairchem Organics Hits 52-Week Low at Rs. 620.35 Amid Ongoing Decline
Fairchem Organics has hit a new 52-week low, reflecting a challenging period for the company as it underperforms the specialty chemicals sector. The stock has declined consecutively over six days, with significant losses over the past year, while broader market indices show positive trends. Financial metrics reveal ongoing operational difficulties.
Read More
Fairchem Organics Hits New 52-Week Low at Rs. 620.35
Fairchem Organics has hit a new 52-week low, continuing a downward trend with six consecutive days of stock price declines. The company has underperformed its sector and experienced a significant drop in net sales and operating profit growth over the past five years, despite maintaining a low debt-to-EBITDA ratio.
Read More Announcements 
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
28-Nov-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for 360 One Blended Fund Series A
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011
28-Nov-2025 | Source : BSEThe Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for 360 ONE Alternates Asset Management Ltd
Announcement under Regulation 30 (LODR)-Newspaper Publication
25-Nov-2025 | Source : BSEPlease find attached herewith newspaper publication regarding Postal Ballot Notice dated November 20 2025
Corporate Actions 
No Upcoming Board Meetings
Fairchem Organics Ltd has declared 75% dividend, ex-date: 04 Aug 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.0%)
Held by 15 FIIs (6.18%)
Fih Mauritius Investments Limited (52.83%)
360 One Special Oppurtunities Fund - Series 7 (3.61%)
18.29%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is -14.91% vs 8.51% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -34.19% vs 98.31% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -20.08% vs -2.78% in Sep 2024
Growth in half year ended Sep 2025 is -89.08% vs 8.84% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -9.30% vs -7.18% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -25.61% vs -9.17% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -13.45% vs -3.94% in Mar 2024
YoY Growth in year ended Mar 2025 is -45.75% vs -6.90% in Mar 2024






